Abstract
Breast cancer in men is rare and is clearly due in some cases to an inherited predisposition. A total of 28 male breast cancer patients were tested for BRCA2 mutations; two frameshifts and one putative missense mutation were identified. One of the frameshifts was detected in the same position as a mutation estimated to be responsible for 40% of all male breast cancer cases in Iceland.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mavraki, E., Gray, I., Bishop, D. et al. Germline BRCA2 mutations in men with breast cancer. Br J Cancer 76, 1428–1431 (1997). https://doi.org/10.1038/bjc.1997.574
Issue Date:
DOI: https://doi.org/10.1038/bjc.1997.574
This article is cited by
-
Mutational analysis of candidate genes in Israeli male breast cancer cases
Breast Cancer Research and Treatment (2018)
-
Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing
Breast Cancer Research and Treatment (2012)
-
Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: The Korean Hereditary Breast Cancer (KOHBRA) Study
Breast Cancer Research and Treatment (2012)
-
Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States
Breast Cancer Research and Treatment (2011)
-
BRCA1/2 mutation analysis in male breast cancer families from North West England
Familial Cancer (2008)
